Recursion Pharmaceuticals (NASDAQ:RXRX) has experienced notable share price fluctuations in 2025, falling 27% year-to-date and trading over 55% beneath its 52-week high of $12. In spite of this ...
Small biotech companies sometimes see their shares skyrocket because of clinical or regulatory progress. That happened this year to Viking Therapeutics and Summit Therapeutics, which gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback